Spray nasal Evkasprey is applied at the following indications:

• symptomatic treatment of congestion of a nose at cold, hay fever, at other allergic rhinitises and ​​ sinusitis;
• for simplification of outflow of a secret at diseases of adnexal bosoms of a nose;
• auxiliary therapy at average otitis (for elimination of hypostasis of a mucous membrane);
• for simplification of carrying out a rinoskopiya.

Structure

Active ingredient - xylomethazolinum a hydrochloride (1 ml of solution contains 1 mg of xylomethazolinum of a hydrochloride).

Excipients: benzalkoniya chloride; dinatrium edetat; sodium dihydrophosphate, monohydrate; sodium hydrophosphate, dodecahydrate; sodium chloride; the castor oil polyethoxylated, hydrogenated; sorbite (E 420); eucalyptus oil; the water purified.

Contraindication

Hypersensitivity to xylomethazolinum or to any other component of medicine, closed-angle glaucoma, transfenoidalny hypophysectomy and surgical interventions with exposure of a meninx in the anamnesis, dry rhinitis (rhinitis sicca) or atrophic rhinitis.

Simultaneous use of MAO inhibitors or their application within 2 weeks before the Evkasprey medicament treatment.

Route of administration

to use Drug to adults and children is more senior than 12 years on one injection in each nasal course to 3 times a day. To apply no more than 3 times in each nasal course in day. Duration of treatment depends on a course of the disease and should not exceed 10 days in a row.

needs to Apply spray as follows: to enter edge of a nozzle of a bottle into each nasal course and to press sharply 1 time a bottle. During injection of air to involve a nose. It is not necessary to reject the head back and to overturn a bottle at spray injection. For prevention of spread of an infection several persons should not use one bottle. The last application is recommended to be carried out just before a dream.

Feature of application

Pregnant

Drug cannot be used during pregnancy because of potential sosudosuzhayushchy effect.

Proof of any undesirable influence on the baby are absent. It is unknown, xylomethazolinum is removed in breast milk therefore the care is necessary, and medicament during feeding by a breast should be used only on doctor's orders.

Evkasprey to apply

to children aged from 12 years.

Drivers

Usually medicine has no

or has insignificant impact on ability to steer vehicles or to work with other mechanisms.

Overdose

inside can lead Excessive topical administration of xylomethazolinum of a hydrochloride or its accidental hit to the profound dizziness, sweating, a znachitelno of decrease in body temperature, a headache, bradycardia, arterial hypertension, respiratory depression, a coma and court. The increased arterial blood pressure can change on lowered. Children of younger age are more sensitive to toxicity, than adults.

to All patients with suspicion on overdose should hold the relevant supporting activities and also, in case of need, urgent symptomatic treatment under control. Medical care has to include observation of the patient within several hours. In case of heavy overdose that is followed by cardiac arrest, resuscitation actions have to continue not less than 1 hour.

Side effects

from nervous system: often (≥ 1/100, <1/10) - a headache.

from respiratory organs, a thorax and mediastinum: often (≥ 1/100, <1/10) - dryness or discomfort from a mucous membrane of a nose.

from a gastrointestinal system: often (≥ 1/100, <1/10) - nausea.

General violations and reactions in the injection site: often (≥ 1/100, <1/10) - burning sensation in the site of application.

to Store

at a temperature not above 25 °C, out of children's reach.

Expiration date - 2 years.